COMMUNIQUÉS West-GlobeNewswire

Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan
05/08/2025
Press Release Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan Exclusive Japanese partner Kowa has initiated a Phase 3 safety clinical trial of NCX 470 for the treatment of ocular hypertension in [...]
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
05/08/2025
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025 UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of European Medicine Agency (EMA) orphan drug [...]
Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
05/08/2025
Has more than 30 years of experience bringing innovations to market, including one of the world’s first drug-eluting coronary stents at Angiotech Pharma Appointment adds world-class capabilities to Tensive as the [...]
CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them
05/08/2025
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells LEHI, Utah, Aug. 05, 2025 (GLOBE NEWSWIRE [...]
Where to Buy Modafinil in the UK: Complete Guide for Smart Buyers in 2025
05/08/2025
This guide provides tips about buying modafinil in the UK, from its uses and modafinil legal status to finding the best place to order and get modafinil with fast shipping. It also spotlights the best modafinil vendor [...]
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
05/08/2025
BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Avis aux médias: L’Hôpital Shriners pour enfants Canada invite les médias à son tournoi de golf annuel
04/08/2025
MONTRÉAL, 04 août 2025 (GLOBE NEWSWIRE) -- Quoi : L’Hôpital Shriners pour enfants Canada convie les représentants des médias à une occasion spéciale de photos et d’entrevues dans le cadre de son tournoi de golf annuel, [...]
Media advisory: Shriners Hospitals for Children Canada Invites Media to its Annual Golf Tournament
04/08/2025
MONTREAL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- What: Shriners Hospitals for Children Canada invites members of the media to attend a special photo and interview opportunity during its Annual Golf Tournament at Summerlea [...]
Dunham House to Partner with CrossMed Healthcare Staffing
04/08/2025
OMAHA, Neb., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Dunham House, a first-of-its-kind, transformational initiative for combat-wounded veterans in need of long-term residential-centered care for their wounds, will partner [...]
Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
04/08/2025
– $28.6 million of Revuforj ® (revumenib) net revenue, representing 43% growth over 1Q25 – – $36.2 million of Niktimvo™ (axatilimab-csfr) net revenue reported by Incyte in first full quarter of launch; $9.4 million in [...]
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
04/08/2025
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and [...]
Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific [...]
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
04/08/2025
Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook
04/08/2025
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally [...]
FibroGen to Report Second Quarter 2025 Financial Results
04/08/2025
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2025 financial results on Monday, August 11 after the markets close. FibroGen will also conduct a conference [...]
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
04/08/2025
FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
04/08/2025
WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Castle Biosciences Reports Second Quarter 2025 Results
04/08/2025
Delivered Q2 2025 revenue of $86 million Q 2 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCypher ® ) increased 33% over Q 2 2024 Raising full-year 2025 revenue guidance range to $ [...]
CVRx Reports Second Quarter 2025 Financial and Operating Results
04/08/2025
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]

Pages